Samsung Biologics secures 98% of PolyPeptide Group in tender offer, acquisition near complete
Squeeze-out threshold of 90% cleared, paving way for full
From the source
Read at mbiz.heraldcorp.comSamsung Biologics secures 98% of PolyPeptide Group in tender offer, acquisition near complete
Squeeze-out threshold of 90% cleared, paving way for full delisting
Source URL https://mbiz.heraldcorp.com/article/10922992
